Good day, everyone, and welcome to Pfizer's Fourth Quarter 2023 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMartino, Chief ...
Fourth-quarter 2023 Cost of Sales(2) as a percentage of revenues increased by 13.4 percentage points compared with the prior-year quarter, driven primarily by the $3.5 billion non-cash Paxlovid ...
Pfizer posted a surprise adjusted fourth-quarter profit, as the company's declining Covid business lost less revenue than expected. The pharmaceutical giant reversed roughly $3.5 billion in revenue ...
Terry Lane is a writer for Investopedia with 25 years of experience in journalism and communications. He covers personal finance, Congress, government regulations, and economics. Bess Adler / ...
MAINZ, Germany, October 16, 2023 (GLOBE NEWSWIRE) -- On October 13, 2023, Pfizer Inc. (NYSE: PFE, “Pfizer”), a collaboration partner of BioNTech SE (BNTX) (Nasdaq: BNTX, “BioNTech” or “the Company”), ...
Pfizer Inc. PFE recently held its fourth-quarter earnings call, revealing a year of contrasts for the pharmaceutical giant. While the company faced setbacks, particularly with its COVID-19 products, ...
Mrinalini Krishna is a former Senior Editor of investing news at Investopedia. She's been a journalist for more than 10 years covering business, personal finance, and investing news. Mario Tama / ...
In the first quarter of 2023, Pfizer established an operating segment, Business Innovation, that includes Pfizer CentreOne (PC1), the company’s global contract development and manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results